Anthem Blue Cross and Blue Shield | CommercialMay 31, 2019
Coding Updates
As a result of coding updates in our claims system, claim edits for the policies and clinical guidelines listed below will be revised. This will result in the review of claims for certain diagnoses before processing occurs to determine whether the service meets medical necessity criteria. As a result, these coding updates may result in a not medically necessary and/or investigational determination.
Effective September 1, 2019, we will be implementing coding updates in the claims system for the following policies listed below which may result in investigational/not medically necessary determinations for certain services.
- GENE.00001 - Genetic Testing for Cancer Susceptibility
- GENE.00007 - Cardiac Ion Channel Genetic Testing
- GENE.00003 - Genetic Testing and Biochemical Markers for the Diagnosis of Alzheimer's Disease
- GENE.00017 - Genetic Testing for Diagnosis and Management of Hereditary Cardiomyopathies (including arrhythmogenic right ventricular dysplasia/cardiomyopathy)
- GENE.00023 - Gene Expression Profiling of Melanomas
PUBLICATIONS: June 2019 Anthem Maine Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/maine/articles/coding-updates-1-2514
Or scan this QR code with your phone